US 11,857,187 B2
Tissue thickness compensator comprising controlled release and expansion
Chester O. Baxter, III, Loveland, OH (US); Frederick E. Shelton, IV, Hillsboro, OH (US); Charles J. Scheib, Loveland, OH (US); Christopher W. Widenhouse, Clarksville, OH (US); William B. Weisenburgh, II, Maineville, OH (US); Samuel P. Tidwell, Cincinnati, OH (US); Stephanie A. Mutchler, Loveland, OH (US); and Gary W. Knight, Lebanon, OH (US)
Assigned to Cilag GmbH International, Zug (CH)
Filed by Cilag GmbH International, Zug (CH)
Filed on Mar. 10, 2021, as Appl. No. 17/197,524.
Application 17/197,524 is a continuation of application No. 16/188,107, filed on Nov. 12, 2018, granted, now 10,945,731.
Application 16/188,107 is a continuation of application No. 13/433,141, filed on Mar. 28, 2012, granted, now 10,123,798, issued on Nov. 13, 2018.
Application 13/433,141 is a continuation in part of application No. 13/097,891, filed on Apr. 29, 2011, granted, now 8,864,009, issued on Oct. 21, 2014.
Application 13/097,891 is a continuation in part of application No. 12/894,377, filed on Sep. 30, 2010, granted, now 8,393,514, issued on Mar. 12, 2013.
Prior Publication US 2021/0290231 A1, Sep. 23, 2021
Int. Cl. A61B 17/072 (2006.01); A61B 17/115 (2006.01); A61B 17/064 (2006.01); A61B 17/00 (2006.01); A61B 17/29 (2006.01); A61B 17/32 (2006.01)
CPC A61B 17/07207 (2013.01) [A61B 17/00491 (2013.01); A61B 17/0643 (2013.01); A61B 17/0644 (2013.01); A61B 17/072 (2013.01); A61B 17/07292 (2013.01); A61B 17/1155 (2013.01); H05K 999/99 (2013.01); A61B 17/2909 (2013.01); A61B 2017/00004 (2013.01); A61B 2017/0053 (2013.01); A61B 2017/00314 (2013.01); A61B 2017/00327 (2013.01); A61B 2017/00477 (2013.01); A61B 2017/00495 (2013.01); A61B 2017/00526 (2013.01); A61B 2017/00818 (2013.01); A61B 2017/00862 (2013.01); A61B 2017/00884 (2013.01); A61B 2017/00889 (2013.01); A61B 2017/00893 (2013.01); A61B 2017/00898 (2013.01); A61B 2017/0725 (2013.01); A61B 2017/07228 (2013.01); A61B 2017/07235 (2013.01); A61B 2017/07242 (2013.01); A61B 2017/07257 (2013.01); A61B 2017/07264 (2013.01); A61B 2017/07271 (2013.01); A61B 2017/07278 (2013.01); A61B 2017/07285 (2013.01); A61B 2017/2908 (2013.01); A61B 2017/2919 (2013.01); A61B 2017/2923 (2013.01); A61B 2017/2927 (2013.01); A61B 2017/2933 (2013.01); A61B 2017/2936 (2013.01); A61B 2017/2946 (2013.01); A61B 2017/320052 (2013.01); F04C 2270/0421 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A staple cartridge, comprising:
a cartridge deck;
a longitudinal slot extending from a proximal end to a distal end through said cartridge deck;
staple cavities defined in said cartridge deck;
staples removably stored in said staple cavities; and
an adjunct positioned on said cartridge deck, wherein said adjunct comprises a biocompatible layer and a tissue-facing surface comprising a hydrogel, wherein said hydrogel is positioned to expand and absorb tissue fluids, and wherein said hydrogel provides compression to the tissue as it expands while absorbing tissue fluids.